IND U19 vs ENG U19, 4th ODI Highlights: Vaibhav Suryavanshi, Vihaan Malhotra star in victory as India seal series


IND U19 vs ENG U19, 4th ODI Highlights: Vaibhav Suryavanshi, Vihaan Malhotra star in victory as India seal series

India Under-19s secured a 55-run victory over England in the fourth Youth ODI at Worcester, taking a 3-1 lead in the five-match series. Batting first after being put in, India posted a commanding 363/9 in 50 overs, driven by a stunning 143 off 78 balls from Vaibhav Suryavanshi and a...

India first Asian team to breach ‘fortress’ Edgbaston


India first Asian team to breach ‘fortress’ Edgbaston

In many ways, Sunday’s defeat marks the most momentous slip-up for England captain Ben Stokes and ‘Bazball’ in an exhilarating cycle that began three years ago. England gunned down 378 against India in Birmingham in 2022, their highest-ever Test chase during the heady early phase...

Neeraj Chopra, the host, organiser and the winner of inaugural NC Classic


Neeraj Chopra, the host, organiser and the winner of inaugural NC Classic

On a windy and cool evening in Bengaluru, javelin throwers at the inaugural Neeraj Chopra Classic battled the conditions which didn’t make life easy for some of the very best. The red and white wind-indicator flags fluttered right through the six rounds. The 800-gram spear changed...

India vs England: Shubman Gill’s marathon double ton singlehandedly puts visitors in charge of second Test


India vs England: Shubman Gill’s marathon double ton singlehandedly puts visitors in charge of second Test

India captain Shubman Gill, it seems, has taken upon himself to ensure that the fans in this transition phase don’t get longingly nostalgic about the era gone by and miss the country’s past batting greats. In just his 34th Test, Gill has overtaken Sachin Tendulkar’s highest individual...

Dengue vaccine a step closer? India’s first phase 3 trial hits 50% enrolment mark, early data shows no safety concerns


Dengue vaccine a step closer? India’s first phase 3 trial hits 50% enrolment mark, early data shows no safety concerns

India has reached the 50 per cent enrolment mark in its first phase III clinical trial for the indigenous tetravalent dengue vaccine, DengiAll, with over 7,000 participants randomised across 20 trial sites. Initial results show no safety concerns for the one-shot vaccine to fight the...

Showing 156 to 160 of 3008 (602 Pages)

Advertisements

Learn English